• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

HCTG Announces Real-Time Patient Consultation Tool


The platform will utilize AI-powered software.

HCTG announced the launch of Consensus AI, a patient consultation tool for healthcare professionals. The platform provides real-time access assistance to HCPs when providing diagnosis.

In a press release, HCTG explained that ConsensusAI analyzes a wide variety of clinical consultations across Healthcasts’ HCP-member network. The AI provides HCPs with insights to assist with diagnosis and treatment selection.

"The compression and acceleration of crowdsourced HCP-provided data is transforming how HCPs are able to deliver superior treatment and improved outcomes for their patients while saving themselves hours of research," HCTG President Erik Dalton said in a press release. "Our investment into technologies that support HCPs and their practices through Healthcasts will result in a faster and more accurate treatment decision for each individual patient."

Healthcasts is described as a platform for HCPs in the US. Members are provided with access to insights thanks to the company’s proprietary AI software.

"Sixty percent of HCPs use Healthcasts during office hours and 66% of HCPs have adjusted their treatment plans based on information exchanged through our platform," said Healthcasts Founder and CEO John Theobald. "With ConsensusAI, HCPs are further empowered to accelerate the clinical use of their own real-world data, transforming how they help themselves, their peers and their patients at the same time."

© 2024 MJH Life Sciences

All rights reserved.